Cite
HARVARD Citation
Kokai-Kun, J. et al. (n.d.). SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study. Open forum infectious diseases. p. S12. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kokai-Kun, J. et al. (n.d.). SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study. Open forum infectious diseases. p. S12. [Online].